Nanomedical applications

Nanoparticles for therapeutics and diagnostics

The application of nanoparticles in medicine and diagnostics is promising and has a number of advantages due to the unique physicochemical properties of the particles. We analyze the specific and non-specific interaction of nanoparticles with biological material such as proteins, cells and tissue. We combine know-how in the synthesis and functionalization of nanoparticles for biomedical applications and in the development of in-vitro tests.

Discover the diverse possibilities of nanoparticles

 

Nanoparticles and biofunctionalization

Synthesis of inorganic and polymeric particles for diagnostics and drug delivery, surface modification, biofunctionalization with target ligands

 

Cell interaction

In vitro cell studies, evaluation of the interaction between nanoparticles and cells

 

Transfer systems

Lipid-based nanoparticles as drug carriers for medicine, customized polymer ligands for the physiological use of inorganic nanoparticles

 

Polymers additives

Polymers as raw materials for cosmetics and as additives for industry and bioeconomy: "green" syntheses, alternatives for petrochemical raw materials, biogenic polymers

 

Cosmetics and cosmeceuticals

New raw materials, tests in formulations, analytics, stability

Cooperation channels

  • contract research
  • research projects
  • feasibility studies
  • development services
  • publicly funded research

We are here for you!

We look forward to your questions, suggestions and requests.

Nanoparticles and biofunctionalization

We synthesize customized nano and micro particles for applications in biomedicine, biosensor technology and bioeconomy. This involves various inorganic cores with diverse functional properties stabilized by different polymers. Alternatively, these structures can be built up layer by layer directly from various polymers that contain cargo molecules such as drugs, proteins, enzymes, fluorescent dyes or nucleic acids. We specifically modify the surfaces to enable interaction with certain types of tissue or cells.

Nanoparticles for biological and bioeconomic applications

  • synthesis of various particle systems
  • phase transfer and biofunctionalization with specific ligands: antibodies, peptides, molecules, sugars, aptamers, nucleic acids
  • introduction of functional groups
  • customized adaptations

Synthesis of ligand systems and dyes

  • chemo- and stereoselective modification of antibodies
  • introduction of targeted elements into molecules for XFI imaging, mass spectrometry and other analytical methods

Analytics

  • dynamic light scattering
  • electron microscopy
  • element-specific concentration determination
  • mass spectrometric analysis
  • protein corona formation
  • labeling with fluorophores
  • ligand binding studies
  • detection of proteins and nucleic acids
  • particle characterization: UV-VIS or fluorescence spectroscopy, relaxometry, thermogravimetric analysis (TGA), MPI, NMR, IR
  • biocompatibility studies

Projects

  • particles as contrast agents for medical imaging, e.g. for magnetic resonance imaging (MRI), magnetic particle imaging (MPI), X-ray fluorescent imaging (XFI)
  • synthesis of labels for target imaging
  • LIBIMEDOTS: functionalization of quantum dots with antibodies for cell phenotyping
  • intercalated dyes for the labeling of extracellular vesicles
  • antibody modifications for imaging
  • surface modification of polymer structures for improved biocompatibility and viability

Publications

  • Feliu N, Parak WJ. Developing future Nanomedicines, Science 384,6694 (2024)
  • Benedict Lemich S, Soltau S, Weißpflog M, Schulze VR, Feliu N, Hankiewicz B, Abetz V.” Defining New Benchmarks of Low CTAB-Concentration-Based Gold Nanorod Synthesis: The Underestimated Potential of Polymer-Directed Anisotropic Growth”. Advance Functional Materials, (2024)
  • Liu Y,  Körnig C, Qi B, Schmutzler O, Staufer T, Sanchez Cano C, Magel E, White JC, Feliu N, Grüner F, Parak WJ, "Size- and ligand-dependent transport of nanoparticles in Matricaria chamomilla as demonstrated by mass spectroscopy and X-ray fluorescence imaging", ACS Nano, 12941-12951 (2022)
  • Chen G, Halim H, Yang H, Zhou Y, Zhu D, Parak WJ, A. Riedinger, Feliu N, " Semiconductor Nanoplatelets as Ultra-Bright Fluorophores for Two-Photon Absorption Cell Imaging", The Journal of Physical Chemistry 126, 5658–5664 (2022)
  • Alkilany AM, Zhu L, Weller H, Mews A, Parak WJ, Barz M, Feliu N. Ligand density on Nanoparticles: A parameter with a critical impact on nanomedicine. Advanced Drug Delivery Reviews. 143, 22-36 (2019)

Cell interaction

The cellular uptake mechanisms, which are influenced by the size, shape and surface properties of the nanoparticles, are crucial for their fate in biological systems. After their uptake into cells, nanoparticles can modulate cellular processes, influence signaling pathways and gene expression and ultimately alter cellular functions. We analyze the interaction of nanoparticles with various cells qualitatively and quantitatively.

Nanoparticles have enormous potential to revolutionize medical applications.

Expertise

  • qualitative and quantitative in vitro studies of specific and non-specific cell interaction
  • customized cell assays
  • visualization of cellular interaction
  • magnetic isolation of individual cells
  • customized consulting
  • mass spectrometric analyses
  • quality assurance

Analytics

  • biocompatibility and toxicology studies
  • internalization, localization of nanoparticles in cells
  • confocal microscopy
  • fluorescence flow cytometry (FFC)
  • biodegradation studies

Projects

  • isolation of specific cells from mixtures using magnetic separation
  • drug delivery for therapeutics
  • colocalization of fluorescent markers
  • biomarker analyses
  • contrast agents for medical imaging

Publications

  • Yan H, Cacioppo M, Megahed, S, Arcudi F, Dordevic L, Zhu D, Schulz F, Prato M, Parak WJ, Feliu N, "Influence of the chirality of carbon n nanodots on their interaction with proteins and cells", Nature Communications 12, 7208 (2021)
  • Roy S, Zhu D, Parak WJ, Feliu N Lysosomal Proton Buffering of Poly(ethylenimine) Measured In Situ by Fluorescent pH-Sensor Microcapsules. ACS Nano. 14, 8012-8023 (2020)
  • Liu Z, Escudero A, Carrillo-Carrion, C, Chakraborty, I, Zhu, D, Gallego M, Parak, WJ, Feliu N. Biodegradation of bi-labelled polymer-coated rare-earth nanoparticles in adherent cell cultures. Chemistry of Materials, 32, 1, 245-254 (2020)
  • Sun X, Gamal M, Nold P, Said A, Pelaz B, Schmied F, von Pückler K, Chakraborty I, Figiel J, Zhao Y, Brendel C, Hasssan M, Parak WJ, Feliu N. “Tracking stem cells and macrophages with gold and iron oxide nanoparticles The choice of the best suited particles”. Applied Materials Today. 15, 267-279 (2019)
  • Feliu N, Neher E, Parak WJ. Toward an optically controlled brain -Noninvasive deep brain stimulation can be achieved by optical triggers. Science 359, 633-634 (2018)

Transfer systems

A physiological environment harbors a large number of influencing factors that need to be taken into account for the targeted intake of foreign material such as active substances, tracers or contrast agents. Modern therapies and medical imaging procedures generally pursue minimally invasive approaches. In order to ensure the targeted application of active substances, among other things, transfer systems are required that meet the corresponding biological requirements. We develop various application-specific solutions ranging from polymer ligands for inorganic nanoparticles to lipid nanoparticles as drug transporters.

Surfactants / lipids

  • synthesis of surfactants and lipids
  • adaptation / functionalization for special target motifs
  • adaptation / functionalization to stabilize the loading

Active ingredient encapsulation

  • targeted encapsulation of active ingredients using microfluidic processes
  • transfer systems for mRNA, autoantigenic peptides and other active ingredients

Ligands / surface modification

  • synthesis of ligands for the physiological use of inorganic nanoparticles
  • established block copolymer ligand systems for the efficient use of quantum dots in nanomedical research

Highly specific and efficient transfer systems are required to transport active substances into cells in a targeted manner.

Liganden / Oberflächenmodifikation

  • Synthese von Liganden zum physiologischen Einsatz von anorganischen Nanopartikeln
  • etablierte Blockcopolymer-Ligandensysteme zum effizienten Einsatz von Quantum Dots in der nanomedizinischen Forschung

Publications

  • Budiarta M, Roy S, Feliu N, Beck T “Overcoming non-specific interactions for efficient encapsulation of doxorubicin in ferritin nanocages for targeted drug delivery”. SMALL, 19(21):e2205606 (2023)
  • Zhu D, Yan H, Zhou Z, Tang J, Liu X, Hartmann R, Parak WK, Shen Y, Feliu N, "Influence of the Modulation of the Protein Corona on Gene Expression Using Polyethylenimine (PEI) Polyplexes as Delivery Vehicle", Advanced Healthcare Materials 10, 2100125 (2021)
  • Zhu D, Roy S, Liu Z, Weller H, Mews A, W. J. Parak N. Feliu “Remotely controlled opening of carrier vehicles inside cells by external triggers upon release of their molecular cargo”, Advanced Drug Delivery Reviews 138:117-132 (2019)

Polymers additives

Polymers are often used as thickeners and stabilizers in creams, lotions and make-up products. They provide the desired texture and prevent the formulation from separating or settling. We develop polymers that are specially tailored to the respective application.

Biopolymers

  • new cosmetic raw materials
  • innovative solutions for the reduction of micro- and liquid plastics in the industry
  • bio-based defoamers
  • emulsifiers
  • UV absorbers
  • modification of nano- and microfibre cellulose
  • novel rheological modifiers

Special polymers

  • acrylates
  • block copolymers
  • polymer particles
  • LNP systems
  • carrier systems
  • core-shell particles

Services

  • development of synthesis processes and upscaling to 5 L
  • optimization and quality assurance
  • environmentally friendly manufacturing processes
  • various synthesis techniques: including radical, anionic, cationic polymerization, ring-opening polymerization
  • characterization of polymers

Projects

  • new material for UV protection
  • bio-based defoamers
  • modification of nanocellulose and application in the food industry
  • emulsifier based on modified starch - testing in formulations
  • surface modification of particles
  • production of acrylate-based thickeners

Analytics

  • gel permeation chromatography (GPC)
  • thermogravimetric analysis (TGA)
  • differential scanning calorimetry (DSC)
  • infrared spectroscopy (FTIR)
  • microscopic methods (TEM, SEM, EDX, FIB, transmitted and reflected light microscopy, fluorescence microscopy, confocal laser scanning microscopy)
  • charge density
  • stability test
  • tensiometry
  • spectroscopic methods (IR, NMR, UV/VIS, NIR, fluorescence lifetime, Raman)
  • rheological properties

Cosmetics and cosmeceuticals

Cosmetics are products that care for, beautify or cleanse the skin. These include make-up, skin care products, hair care products, perfumes and other items. Cosmeceuticals are a mixture of cosmetics and pharmaceuticals. They contain active ingredients that go beyond purely cosmetic effects and have a certain therapeutic effect. We develop both cosmetics and cosmeceuticals. With our many years of expertise, we are happy to support you with questions and the development of customized solutions.

Analytics

  • rheological measurements
  • microscopic images
  • shelf-life tests
  • stability tests
  • tests of raw materials in different formulations
  • quality control

Services

  • development of new raw materials and alternatives to current petrochemical-based raw materials
  • new systems based on active raw materials and inorganic particles
  • stabilisation of particulate additives in various products
  • targeted encapsulation of active ingredients using microfuidic processes
  • transfer systems for active ingredients

Patents

  1. DE102019200135A1 Zubereitung mit Vinylamine/N-vinylformamide Copolymer beschichteten Siliciumdioxidpartikeln – Aleksandrovic-Bondzic V., K. Berndt, Heinrich S. Eichner E., Traupe P.
  2. DE102019200138A1 Zubereitung mit Vinylamine/N-vinylformamide Copolymer beschichteteten Cellulosepartikeln- Aleksandrovic-Bondzic V., K. Berndt, Traupe B.
  3. US10023668 (B2)  -  Thickened Polymer , Aleksandrovic-Bondzic V, Mertens S., Foerster S.
  4. DE102011119332 (A1)  -  Verwendung von über radikalische Emulsionspolymerisation erhältlichen Polymeren als Verdicker für Reinigungsmittel, Aleksandrovic-Bondzic V, Mertens S.
  5. WO2011033040 (A2)  -  Antibacterial particles and their synthesis , Aleksandrovic-Bondzic V., Schlundt C. R., Werner K., Woost M.

Glossary

Here you will find explanations of frequently used terms.

  • Nanoparticles are tiny particles that are dimensioned in the nanometer scale (1 nanometer = 1 billionth of a meter). They are made of different materials such as metals, semiconductors, polymers or organic substances and can have a variety of shapes, including spheres, rods or complex structures. Due to their tiny size, nanoparticles often exhibit unique physical, chemical or optical properties that render them attractive for a wide range of applications.

    Nanoparticles are used in various fields such as medicine (e.g. for targeted pharmaceutical delivery), electronics (e.g. for improved sensors or displays), environmental technology (e.g. for water treatment) and cosmetics (e.g. for sunscreens). 

  • Transfer systems are special technologies or carrier systems that are used to transport or deliver drugs to specific areas of the body. These systems can be designed in various ways to improve the efficacy, safety and targeted application of drugs. The most common transfer systems include:

    Liposomes: These are man-made vesicles made up of lipid layers that can trap active ingredients in their hollow chambers. Liposomes can be used to transport and control the release of drugs.

    Nanoparticles: These are very small particles in the nanometer range that can consist of different materials (e.g. metals, polymers). Nanoparticles can enclose active substances or carry them on their surface and thus facilitate their uptake into cells or tissue.

    Polymer-based microparticles:
    These are small particles of polymers that can contain and release active ingredients in a controlled manner. They are often used to extend the retention time of drugs in the body or to release them in a targeted manner.

    Hydrogels and nanogels: These are networks of water and polymers that can trap active ingredients and act as a matrix to deliver drugs locally.

    Dendrimers:
    These are synthetic molecules that have a tree structure and can enclose active substances in their branches. They are being investigated for various medical applications, including targeted drug delivery.

    Transfer systems play a crucial role in modern medicine as they can help to target drugs, control their release and reduce side effects by minimizing uptake into healthy tissues and maximizing concentration in diseased tissues or cells.

  • The term "cosmeceutical" is a combination of the words "cosmetics" and "pharmaceuticals", as these products combine properties from both areas. They contain active ingredients that go beyond purely cosmetic effects and have a certain therapeutic effect on the skin.

    In contrast to pure cosmetics, cosmeceuticals can contain higher concentrations of active ingredients that have proven positive effects on the skin. These active ingredients can have antioxidant, anti-inflammatory, moisturizing or anti-aging properties, for example.

    Cosmeceuticals are often used to treat specific skin problems such as acne, wrinkles, hyperpigmentation or for general skin care. They fall between purely cosmetic products, which primarily offer aesthetic improvements, and pharmaceutical preparations, which have to meet stricter regulatory requirements and are often used for medical purposes.

  • Biofunctionalization refers to the process by which biological molecules, such as proteins, enzymes, antibodies or DNA, are specifically bound to the surfaces of materials or nanoparticles. This is typically done by chemical or physical methods to modify the surface with biologically active molecules.

    The main objectives of biofunctionalization are:

    Improving biocompatibility: By binding biological molecules, materials can interact better with biological systems, which improves their compatibility and their use in biological or medical applications.

    Enhancement of functionality: The bound biological molecules can confer specific functions, such as the recognition of target structures (e.g. specific cells or pathogens) or the modulation of biological processes.

    Examples of biofunctionalization include the binding of antibodies to the surfaces of biosensors for the detection of pathogens, the modification of nanoparticles with peptides for the targeted delivery of drugs or the immobilization of enzymes on carrier materials for the catalytic conversion of substrates.

    In nanotechnology and biotechnology, biofunctionalization plays a decisive role in equipping materials with specific biological functions and expanding their applications in areas such as medicine, diagnostics, environmental technology and food technology.

  • Rheology is the study of the flow behavior of liquids and viscoelastic materials. A rheology modifier is used to influence the viscosity and flow properties of a material. These modifiers are used in various industries such as cosmetics, the paint and coatings industry, the food industry, the building materials industry and the pharmaceutical industry. They help to improve the processing properties of materials, increase stability and achieve the desired properties of the end product.

  • Defoamers are chemical substances that are used to reduce or prevent the formation of foam in industrial processes. Foam is created by trapping air bubbles in a liquid and can have undesirable consequences in various industries, such as food processing, chemical production, paper manufacturing and wastewater treatment.

    The use of defoamers aims to control the formation of foam and improve the stability of products or processes. They act by reducing the surface tension of the liquid or suppressing the formation of air bubbles. Defoamers typically consist of surface-active substances that are able to destabilize and destroy air bubbles.

  • Emulsifiers are substances that are used to stabilize an emulsion. An emulsion is a mixture of two normally immiscible liquids, such as oil and water. Emulsifiers have the ability to reduce the interfacial tension between these two liquids and prevent the phases from separating again. They help to stabilize finely dispersed particles of one liquid (e.g. oil) in the other liquid (e.g. water).

    Bioemulsifiers are emulsifiers that are obtained naturally or come from natural sources. They can be obtained from plant or animal sources, such as vegetable oils, beeswax or certain proteins. They can also be biodegradable.

    Both types of emulsifiers are used in numerous applications, including in the food industry (to produce emulsions such as mayonnaise or salad dressings), in cosmetics (to stabilize creams and lotions), in pharmaceuticals (to produce drug emulsions) and in agriculture (to improve the effectiveness of crop protection products).

  • An emulsion is created by mixing two or more non-mixable liquids, typically in the form of an oil-water mixture. In this mixture, finely dispersed droplets of one liquid are evenly distributed in another liquid. An emulsion usually consists of a dispersed phase, in which the fine droplets are located, and a continuous phase, which is the liquid in which the droplets are dispersed.

    There are two main types of emulsions: Oil-in-water (O/W) and water-in-oil (W/O). In an oil-in-water emulsion, the oil droplets are distributed in the water phase, whereas in a water-in-oil emulsion, the water droplets are distributed in the oil phase.

    Emulsions play a crucial role in various fields such as the food industry (e.g., in salad dressings and mayonnaise), cosmetics (e.g., in creams and lotions), and the pharmaceutical industry (e.g., in drug formulations). They make it possible to combine different ingredients that are normally immiscible into a homogeneous and stable form, leading to improved product characteristics such as uniform distribution, increased shelf life, and optimal functionality.

  • The use of UV absorbers is crucial to protect both human skin and materials from the harmful effects of UV radiation. They play a central role in maintaining material integrity and skin health by effectively absorbing UV rays and converting them into harmless heat.

    Application in sunscreens: In the cosmetics industry, UV absorbers are essential ingredients in sunscreens. They prevent UV rays from penetrating the skin and causing damage that can lead to premature skin ageing and skin cancer. Protection is mainly achieved through absorption, with around 90 per cent of the protective effect being attributable to this mechanism.

    Protection of materials: UV absorbers are used in coatings, plastics and paints to minimise the effects of UV radiation. This radiation can lead to colour loss, cracking and the degradation of materials. By absorbing UV radiation, UV absorbers convert the energy into harmless heat, thereby preserving the physical and optical properties of the materials.

    Types of UV absorbers: UV absorbers can be divided into organic and inorganic types. Organic absorbers such as benzophenones and hydroxybenzophenones are commonly found in sunscreens, while inorganic absorbers such as zinc oxide and titanium dioxide are used in various applications, including cosmetics and coatings.

Contacts

Neus Feliu Torres

Contact Press / Media

Dr. Neus Feliu Torres

Head of department | Nanomedical applications; Head of group | Nanoparticle-based theranostics

Fraunhofer IAP
Grindelallee 117
20146  Hamburg

Vesna Aleksandrovic-Bondzic

Contact Press / Media

Dr. Vesna Aleksandrovic-Bondzic

Head of group | Sustainable polymers / Home & personal care

Grindelallee 117
20146  Hamburg

Phone +49 40 2489639-12

Marcus Janschel

Contact Press / Media

Dr. Marcus Janschel

Head of group | Physiologically active nanostructures

Fraunhofer IAP
Grindelallee 117
20146  Hamburg

Phone +49 40 2489 639 41